Gut Microbiome Pill

Completed · Not applicable

Conditions studied: Healthy

In brief

The purpose of this study is to evaluate the safety and efficacy of a 3D-printed ingestible pill designed to sample microbiota from the GI tract, focusing on the ability to collect data also from the small intestine. The study also aims to assess ease of use and transit time.

Key facts

Study ID

NCT07243756

Run by

NYU Langone Health

People needed

10

Starts

2026-01-21

Expected to finish

2026-04-20

Last updated by the study team

2026-05-04

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy adults aged 18-65.
• Willing and able to provide informed consent.
• Able and willing to comply with study procedures, including pill ingestion, stool collection, follow and record dietary instructions, and fill questionnaires.

You may not qualify if…

• History of gastrointestinal diseases (e.g., Crohn's disease, irritable bowel syndrome, small intestinal bacterial overgrowth).
• History of abdominal surgery that may impact gastrointestinal function (e.g., bowel resection, bariatric surgery).
• Known allergies or intolerances to medical devices or ingestible capsules.
• Recent antibiotic use (within 3 months) that may affect gut microbiome results.
• Use of medications that alter GI motility such as laxatives or prokinetics.
• Known anatomical abnormalities or strictures in the GI tract that increase the risk of obstruction.
• Pregnant, planning pregnancy or breastfeeding, since pregnancy and breastfeeding affect the microbiome, Exclusion of pregnancy will be confirmed by the date of the last menstrual period.
• Participation in another investigational trial within the last 30 days.

Where it is running

• NYU Langone Health — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.